Results 81 to 90 of about 7,418 (172)

The Effect(s) of Matricaria chamomilla on Leishmania major Ulcers in Balb/c Mice

Armaghane Danesh Bimonthly Journal, 2015
Background & aim: Treatment of cutaneous leishmaniasis (CL) is based on the use of pentavalent antimony compounds as injection drug with highly side effects.
AR Dashtpeima, AA Moshfe, L Manzoori, N Arefkhah, S Shahryari, M Mohseni, M Abbasi, J Noushadian   +7 more
doaj  

Investigating macrophage polarization in cutaneous leishmaniasis

Journal of Vector Borne Diseases
Background & objectives: Cutaneous leishmaniasis (CL) is reported as the most neglected tropical disease. The polarization of macrophages such as M1 or M2 phenotypes significantly affects the development of leishmaniasis.
May AlMoshary
doaj   +1 more source

Experimental Cutaneous Leishmaniasis

Journal of Investigative Dermatology, 1963
Zuckerman, Avivah, Sagher, Felix
openaire   +1 more source

Therapeutic efficacy of butenafine nanomedicines in experimental cutaneous leishmaniasis [PDF]

, 2019
The production of ergosterol lipid, important for the Leishmania membrane homeostasis, involves different enzymes. This pathway can be blocked to azoles and allylamines drugs, such as the antifungal butenafine chloride. This drug was active (in vitro) against L. (L.) amazonensis and L.
Passero, Luiz Felipe D., Sousa, A. B., Jesus, J.A., Lalatsa, Katerina, Laurenti, M. D.   +4 more
openaire   +1 more source

A Human Monoclonal Antibody Targeting α-Gal Ameliorates Experimental Cutaneous Leishmaniasis. [PDF]

J Infect Dis
Cho H, Paun A, Seo Y, Lee SH, Traver M, Zhao M, Skinner J, Tan J, Sacks DL, Crompton PD.   +9 more
europepmc   +1 more source

Nanoformulated <i>Walterinnesia aegyptia</i> Venom Enhances Therapeutic Outcomes in Experimental Cutaneous Leishmaniasis: A Comparative Study of Hyaluronic Acid and Silver Nanoparticles. [PDF]

Nanomaterials (Basel)
Al-Aqil A, Al Nasr IS, Hakami H, Abou El Fadl F, Wang C, Al-Shammari M, Alotaibi S, Alotaibi S, Al-Qurashi A, Al-Rashid H, Al-Olayan E.   +10 more
europepmc   +1 more source

Topical AuNPs-Cys-Sm29 gel modulates the course of lesion development in experimental cutaneous leishmaniasis. [PDF]

PLoS Negl Trop Dis
Viana SM, Cardoso L, Borba PB, Carvalho LP, Moreira J, Mambelli F, Oliveira SC, Carvalho EM, de Oliveira CI.   +8 more
europepmc   +1 more source

Biocompatibility and Effectiveness of Amphotericin B-Loaded Metal-Organic Structures (AmB-ZIF-8) as Dermal Drug Transporters in Experimental Cutaneous Leishmaniasis. [PDF]

J Exp Pharmacol
Carreño H, Osorio J, Mejía-Ospino E, Escobar P.   +3 more
europepmc   +1 more source

Dicentrine Purified from the Leaves of Ocotea puberula Controls the Intracellular Spread of L. (L.) amazonensis and L. (V.) braziliensis Amastigotes and Has Therapeutic Activity as a Topical Treatment in Experimental Cutaneous Leishmaniasis. [PDF]

Microorganisms
Jesus JA, Araujo Flores GV, Souza DCDS, Tristão DC, Serrano DR, Lalatsa A, Laurenti MD, Lago JHG, Ferraz HG, da Silva RP, Passero LFD.   +10 more
europepmc   +1 more source

The ecoepidemiology of cutaneous leishmaniasis in Ethiopia: a systematic review and meta-analysis. [PDF]

Parasit Vectors
Ayana GM, Daba DB, Ejigu BA, Wendimu DE, Belina M, Molla E, Hailemeskel E, Asefa A, Shumie G, Nigusse T, Barhoumi M, Guerbouj S, Ben-Salah SF, Tafesse T, Keto HB, Woldemeskel M, Cherkose T, Jira SC, Aissa-Haj JB, Sicuri E, Guizani I, Gadisa E.   +21 more
europepmc   +1 more source